Mutual of Omaha Life Insurance Fit Review for COPD

Research Snapshot

Why Mutual of Omaha Qualified for This Study

Questions This Section Answers

• Is Mutual of Omaha a good choice for Life Insurance for COPD?
• How many AI platforms named Mutual of Omaha for COPD life insurance?

Mutual of Omaha qualified because every included platform named it during ranking discovery and it finished first overall. All 7 platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — listed it, giving it a 100% mention share and an average listed rank of 5.14, with a best rank of 1 (deepseek) and a final rank of 1. Its ranks varied widely by platform: deepseek 1, google 3, anthropic 6, grok 6, perplexity 6, kimi 7, and openai 7.

The reason it appeared on every list is structural rather than a quality verdict: Mutual of Omaha publishes guaranteed-issue and simplified-issue whole life products that do not require a medical exam, which is directly relevant to a COPD applicant who may struggle with full underwriting ^[1]. Independent reviews also singled it out for smokers with lung conditions or supplemental oxygen use ^[4].

Platform fit ratings were not unanimous: kimi rated it "strong," anthropic, google, and openai rated it "good," and deepseek, grok, and perplexity rated it "mixed." That spread is itself a finding — the platforms agree the carrier is relevant but disagree on how good the fit is.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for COPD

Questions This Section Answers

• Which Mutual of Omaha plan should a COPD applicant choose if they need guaranteed acceptance?
• Is Mutual of Omaha's Living Promise Level Benefit available to someone with a COPD diagnosis?

The most relevant Mutual of Omaha products for a COPD applicant are its permanent whole life and final-expense lines, not its fully underwritten term products. The platforms converged on three product families.

Guaranteed Whole Life / Guaranteed Issue Whole Life. Company material states this product is available for ages 45-85, with a narrower New York range of 50-75, requires no medical exam, and is not subject to medical underwriting ^[6]. A USAA announcement of the underwritten product describes it as requiring no medical exam or questionnaire with fixed premium and face value ^[9].

Living Promise Whole Life. This is a simplified-issue whole life product with Level Benefit and Graded Benefit designs ^[10]. Producer materials list Level Benefit issue ages 45-85 with face amounts shown as $2,000-$50,000, and Graded Benefit issue ages 45-80 with face amounts of $2,000-$20,000 ^[12]. Independent sources describe Living Promise as available for ages 45-85 with no exam ^[13].

Term Life Express. A simplified-issue term product with a telephone interview and health questionnaire, no medical exam, ages 18-65, and coverage of $25,000-$300,000 ^[14]. Producer materials describe issue ages and face amounts varying by age, including $25,000-$300,000 for ages 18-50, with 10-, 15-, 20-, and 30-year terms and conversion to simplified-issue permanent products ^[15].

The critical product-selection fact: a COPD diagnosis generally disqualifies an applicant from the Living Promise Level Benefit and routes them to the Graded Benefit or guaranteed-issue pathway ^[16]. One source states Level Benefit is available only to applicants answering "no" to all health questions ^[20].

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Mutual of Omaha for COPD life insurance?
• Does Mutual of Omaha require a medical exam for COPD applicants?

The platforms agreed on several points, though not unanimously on every detail.

Guaranteed-issue availability and age range. Multiple platforms cited ages 45-85 with a New York variation of 50-75 ^[21]. This was the most consistently repeated fact across the responses.

COPD routes applicants to graded or guaranteed products. Anthropic, google, and grok all reported that a COPD answer on the health questionnaire pushes applicants away from Level Benefit toward graded or guaranteed issue ^[24]. This was a strong, multi-platform agreement.

Low face amounts. Platforms agreed that guaranteed-issue and final-expense coverage is capped at modest amounts. The consumer quote page lists $2,000-$25,000 ^[28], and independent sources describe guaranteed-issue caps in the $10,000-$25,000 range ^[29].

A two-year limited benefit period. Company material states guaranteed whole life includes a two-year limited benefit period ^[30]. Independent sources describe the graded benefit as returning premiums plus roughly 10% interest for natural-cause deaths in the first two years ^[32].

Fixed premiums. Company pages state whole-life premiums do not increase with age after enrollment and coverage continues if policy requirements are met ^[34].

Strong financial ratings. Anthropic cited A+ with A.M. Best, A+ with the Better Business Bureau, and A1 with Moody's ^[36]. This is platform-reported and not independently verified in this study.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• What is uncertain about Mutual of Omaha's COPD underwriting thresholds?
• Do the AI platforms disagree about Mutual of Omaha's maximum coverage for COPD applicants?

The platforms disagreed or were uncertain on several material points, and buyers should treat these as open questions rather than settled facts.

Maximum coverage amount. The consumer quote page lists guaranteed whole-life coverage of $2,000-$25,000 ^[38], while producer materials list Living Promise Level Benefit coverage up to $50,000 ^[39]. Independent sources cite $25,000 ^[40], $40,000 ^[41], and $25,000-$50,000 ^[42]. This likely reflects different products, states, channels, or updated underwriting rules, but the conflict is unresolved in the supplied evidence.

Whether Living Promise is guaranteed issue or simplified issue. Perplexity flagged that public sources conflict on whether Living Promise is strictly no-health-question guaranteed issue or simplified issue with health questions ^[43]. This distinction matters because simplified issue can still decline an applicant.

COPD-specific underwriting thresholds. The cited public materials do not disclose Mutual of Omaha's thresholds for pulmonary-function results, oxygen use, exacerbations, smoking history, or hospitalizations ^[45]. No platform could state which COPD severity level produces Level, Graded, rated, postponed, or declined outcomes.

Term Life Express applicability to COPD. One platform described it as available for "moderate health risks" but could not confirm whether COPD is an automatic decline or a case-by-case determination ^[47].

Fit rating spread. Kimi rated the fit "strong," anthropic, google, and openai rated it "good," and deepseek, grok, and perplexity rated it "mixed." The disagreement centers on whether guaranteed access outweighs the coverage caps and premium cost.

Graded benefit period length. Most sources describe a two-year period, but one source cites a 2-3 year range ^[49]. The exact formula should be verified in the state-specific policy.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What features make Mutual of Omaha suitable for a COPD applicant who uses supplemental oxygen?
• Can a COPD applicant get immediate full coverage from Mutual of Omaha?

The features most relevant to a COPD buyer are the ones that remove or reduce underwriting barriers, and the ones that limit early payout.

No medical exam on guaranteed-issue and simplified-issue products. Company material states guaranteed whole life is not subject to medical underwriting ^[50]. Simplified-issue products skip the exam but still ask health questions and may check prescription or medical data ^[52].

Acceptance pathway for severe COPD and oxygen use. Independent research identifies Mutual of Omaha as a strong choice for current smokers with lung conditions requiring supplemental oxygen ^[54]. Guaranteed issue is positioned as accessible regardless of COPD severity for eligible ages ^[56].

Level vs. Graded Benefit design. Living Promise offers a Level Benefit for applicants who answer "no" to all health questions and a Graded Benefit for those who do not ^[57]. The Graded Benefit does not distinguish tobacco status in the cited guide ^[59].

Riders. Living Promise Level Benefit materials list an accelerated death benefit for terminal illness or nursing-home confinement and an optional accidental-death benefit rider; the cited Graded Benefit materials list no riders ^[59]. Availability may vary by state and policy form.

Term conversion. Term Life Express can convert to simplified-issue permanent products, subject to applicable terms and state variation ^[60].

Cash value and lifetime coverage. Whole life builds cash value and provides lifetime coverage if premiums are paid ^[61].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Mutual of Omaha guaranteed whole life cost per month for a COPD applicant?
• What fees and waiting-period terms apply to Mutual of Omaha's graded benefit for COPD?

Exact COPD-specific premiums are not publicly verifiable from the cited sources, because simplified-issue pricing depends on age, sex, tobacco status, state, coverage amount, and underwriting outcome ^[63]. The figures below are illustrative or average, not quotes.

Published illustrative premiums. Company examples show average monthly premiums for $15,000 of guaranteed whole-life coverage ranging from roughly $48.19-$72.30 at ages 50-54 to $192.16-$288.66 at ages 80-84, depending on sex ^[63]. One platform cited sample guaranteed-issue quotes of about $32/month for a 50-year-old female and $43/month for a male for $10,000 ^[65]. Google cited approximately $32.46/month for a 50-year-old female and $42.81/month for a male for a $10,000 benefit ^[66]. Another source cited guaranteed-issue rates starting as low as $8.84 per month ^[67]. These ranges are inconsistent and should not be treated as quotes.

Policy fees. Producer materials list annual policy fees of $36 for Living Promise Level Benefit and $12 for Graded Benefit ^[68].

Loan charges. The cited producer material lists a 7.4% advance loan charge if policy loans are used ^[68].

Graded benefit payout. During the first two years, natural-cause deaths pay a return of premiums plus roughly 10% interest rather than the full face amount ^[69]. Accidental deaths typically pay the full benefit immediately ^[69].

Premium behavior. Whole-life premiums are fixed after issue and do not increase with age ^[71]. Term coverage ends when the term expires unless renewed or converted, and renewal premiums may increase ^[73].

Cancellation and lapse. Guaranteed whole-life coverage requires premiums to remain current; cancellation or lapse can reduce or terminate coverage and may affect cash value ^[63]. One platform cited a 30-day money-back guarantee ^[69].

Best Suited For

Questions This Section Answers

• Who is Mutual of Omaha best suited for among COPD life insurance buyers?
• Is Mutual of Omaha a good fit for a COPD applicant who has been declined elsewhere?

Mutual of Omaha is best suited for COPD applicants who prioritize acceptance over coverage size or cost.

The strongest fit is an applicant age 45-85 who needs roughly $2,000-$25,000 of guaranteed-issue final-expense coverage and cannot obtain affordable traditionally underwritten coverage ^[74]. Applicants with moderate or uncertain health who may qualify for simplified-issue Living Promise coverage are also a reasonable fit ^[76]. Applicants with severe COPD, oxygen dependence, or recent hospitalizations who have been declined elsewhere are a commonly cited fit, because guaranteed issue removes the underwriting barrier ^[77].

Buyers focused on funeral costs or small debts rather than income replacement are the clearest match, since final-expense face amounts and fixed premiums suit that goal ^[79].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Mutual of Omaha for Life Insurance for COPD?
• Is Mutual of Omaha a poor fit for a younger COPD applicant needing large coverage?

Several buyer profiles are poor fits for these specific products.

Applicants under age 45 cannot access the guaranteed-issue product, since it is limited to ages 45-85 ^[81]. Applicants needing large death benefits for mortgage, income replacement, or estate planning will find the guaranteed-issue caps insufficient ^[83]. Applicants with mild, stable COPD who are willing to complete full underwriting should compare medically underwritten term policies across multiple carriers first, because those may offer more coverage or better value ^[85]. Applicants in New York or other states where issue ages, face amounts, or product availability differ should verify state-specific terms before applying ^[81].

Buyers who cannot accept a two-year limited benefit period or higher premiums per dollar of coverage should also look elsewhere ^[88].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Mutual of Omaha for a COPD buyer who needs more than $25,000 in coverage?
• When should a COPD applicant choose a fully underwritten term policy instead of Mutual of Omaha?

Another option may be better in several specific situations, and the platforms named alternatives.

If the applicant has mild, stable COPD and is a non-smoker, fully underwritten term policies from carriers such as Transamerica, Protective, or Pacific Life may offer lower rates (anthropic, platform-reported). If the applicant needs coverage above roughly $25,000-$40,000, carriers with higher guaranteed-issue caps or simplified-issue term options may be a better fit (anthropic, platform-reported). If the applicant is under age 45, Mutual of Omaha's guaranteed-issue product is unavailable and traditional term or other guaranteed-issue carriers should be evaluated (openai, platform-reported).

If the applicant needs immediate full coverage with no waiting period, some carriers offer level-benefit final expense products for applicants with COPD history; one source specifically names Americo Eagle Premier as providing immediate coverage for COPD compared with standard waiting periods ^[90]. If cost is the primary concern and the applicant is medically approvable, a fully underwritten policy may be cheaper per dollar of coverage ^[91].

These alternative names are platform-reported and were not independently verified in this study.

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Mutual of Omaha before signing a COPD life insurance contract?
• Which insurer will actually issue the Mutual of Omaha policy?

Before applying, a COPD buyer should confirm the following with Mutual of Omaha or a licensed agent. These items come from the platforms' verification lists and the supplied uncertainty disclosures.

• Which legal insurer will issue the policy: Mutual of Omaha Insurance Company or United of Omaha Life Insurance Company (openai, platform-reported)?
• For the applicant's state, age, COPD severity, smoking status, oxygen use, medications, pulmonary-function results, and hospitalization history, is Level Benefit, Graded Benefit, guaranteed issue, or term available ^[93]?
• Will the application require medical records, a pulmonary-function test, prescription-history review, a medical-data check, a phone interview, or an attending-physician statement ^[95]?
• What exact death benefit applies if death occurs during the first two policy years ^[97]?
• What are the guaranteed premiums, policy fee, cash value, nonforfeiture options, and lapse/reinstatement rules ^[93]?
• What is the maximum face amount available in the applicant's state and through the intended sales channel ^[99]?
• If applying for term insurance, what are the term length, renewal premiums, conversion deadline, conversion products, and COPD-related underwriting requirements ^[100]?
• Are the accelerated death benefit and accidental-death riders included, optional, excluded, or unavailable in the applicant's state ^[93]?
• Would an independent broker obtain informal underwriting opinions from multiple carriers before submitting a formal application (openai, platform-reported)?
• Are there pending or recent COPD exacerbations, oxygen prescriptions, hospitalizations, smoking changes, or medication changes that should be disclosed and documented before applying ^[101]?

Final AI Consensus Verdict

Mutual of Omaha is a good, but not universally best, fit for U.S. consumers with COPD. All 7 platforms named it during ranking discovery, and it finished first overall, but platform fit ratings ranged from "strong" to "mixed," and the platforms disagreed on maximum coverage and on whether Living Promise is guaranteed issue or simplified issue.

Its strongest use case is age-45-to-85 final-expense coverage where guaranteed acceptance or simplified underwriting matters more than low cost or a large death benefit. Applicants with mild, stable COPD should compare fully underwritten term insurance first, while applicants with severe or unstable COPD should compare Mutual of Omaha's guaranteed-issue terms against other guaranteed-issue and impaired-risk carriers. The two-year limited benefit period, low face amounts, and higher premiums per dollar of coverage are the main trade-offs. AI-platform agreement does not prove product quality; it reflects consistent positioning across the reviewed responses.

How This Review Was Produced

This review evaluates Mutual of Omaha only for the Life Insurance for COPD use case. It draws on the supplied platform responses from 7 platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — plus the supplied citation catalog and official-page excerpts. Platform fit ratings, product names, and pricing figures are platform-reported and were not independently verified by the writer stage. The study date is 2026-09-22.

Methodology Limitations

Several limitations apply. Platform-reported research dates differ from the authoritative run date: deepseek reported 2026-01-15, while the other six platforms reported 2026-09-22. Deepseek's response was produced with search disabled, so its claims require explicit verification before being treated as current facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts.

The cited public materials do not disclose Mutual of Omaha's COPD-specific underwriting thresholds, so no source can predict whether a specific applicant will receive Level, Graded, rated, postponed, or declined coverage. Published premium examples are illustrative or average figures and should not be treated as quotes for a COPD applicant. Product forms, state availability, underwriting rules, and prices can change; the application and policy documents control. Platform agreement on a finding does not establish that the product is high quality.

Explore more life insurance guidance in the category directory.